北美胃轻瘫市场预测至 2028 年 - COVID-19 影响和区域分析（按类型（特发性、糖尿病、术后等）、药物类别（促动力剂、肉毒杆菌毒素注射剂和止吐剂）和分销渠道（零售）药房、医院药房等）
No. of Pages: 115 | Report Code: TIPRE00024816 | Category: Life Sciences
No. of Pages: 115 | Report Code: TIPRE00024816 | Category: Life Sciences
北美是最大的胃轻瘫市场，其中美国占有最大的市场份额，其次是加拿大。北美增长的特点是胃轻瘫患病率上升。此外，人口老龄化和糖尿病患病率的上升预计也将为预测期内北美胃轻瘫市场的增长提供利润丰厚的机会。此外，制药和生物技术公司的广泛研究预计将进一步刺激北美胃轻瘫市场的增长。
尽管医疗保健行业在过去几年见证了SARS、H1N1和其他疾病的爆发，但由于其传播方式，COVID-19 的严重性使情况变得更加复杂。自 COVID-19 爆发以来，北美地区的病例数量不断增加。在患有慢性胃肠道疾病的患者中，COVID-19 最初可能表现为潜在胃肠道疾病的突然发作，因为历史上病毒与胃肠道疾病（包括胃轻瘫）的恶化有关。此外，根据世界胃肠病学组织的数据，观察到出现 COVID-19 症状后胃肠道并发症有所增加。 COVID-19 患者可能会抱怨消化系统症状，例如食欲不振、恶心、呕吐、腹泻、症状或先前存在的消化系统疾病（例如炎症性肠病）的疾病活动性。然而，根据 2016 年发表的《社区药剂师糖尿病性胃轻瘫》综述，美国有超过 2910 万人患有糖尿病并面临与该疾病相关的并发症。糖尿病是导致胃轻瘫的最常见全身性疾病。此外，根据美国国家生物技术信息中心 (NCBI) 2020 年 9 月发布的数据，如果仔细考虑恶心和呕吐作为 COVID-19 的症状，则令人惊讶，因为它可能是早期出现的症状。因此，已观察到促动力剂和止吐剂的销售量有所增加。然而，由于供应链中断以及政府命令限制了针对 COVID-19 的某些活动，包括改变现场运营以减少制造能力和实施社交距离，供应商的订单减少了。根据需求采购、运输原材料的能力、停工、放缓和延误，市场可能会出现放缓。
北美胃轻瘫市场预计从2020年的1,488.03百万美元增长到2027年的2,032.27百万美元；预计2020年至2027年复合年增长率为4.6%。制药和医疗器械公司正专注于研发，开发治疗胃轻瘫的新产品。学术机构和研究中心也积极参与药物发现。 2018 年 12 月，国际胃肠道疾病基金会宣布设立 AGA-Shire 研究学者奖，以促进功能性胃肠道 (GI) 和动力障碍的研究。该组织宣布拨款约 30 万美元以及其他设施。此类研究的结果预计将推动市场新产品的开发，这将为预测期内胃轻瘫市场参与者的增长提供有利可图的机会。
北美胃轻瘫市场根据类型进行细分，药品类别、分销渠道和国家。北美胃轻瘫市场按类型分为特发性胃轻瘫、糖尿病性胃轻瘫、手术后胃轻瘫等。特发性细分市场在 2019 年占据最大市场份额。北美胃轻瘫市场按药物类别分为促动力剂、肉毒毒素注射剂和止吐剂。促动力剂细分市场在2019年占据最大市场份额。根据分销渠道，北美胃轻瘫市场分为零售药房、医院药房等。 2019年，医院药房领域占据了最大的市场份额。根据国家/地区，北美胃轻瘫市场分为美国、加拿大和墨西哥。 2019 年，美国占据最大的市场份额。
准备本报告时参考的一些主要一手和二手来源北美胃轻瘫市场上的信息包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有Allergan Plc； ANI 制药公司； Bausch Health Companies Inc.（Salix Pharmaceuticals, Ltd.）； Cinrx Pharma, LLC（Cindome Pharma）；埃沃克制药； Ipca 实验室有限公司；强生服务公司； NEUROGASTRX 公司；辉瑞公司；和梯瓦制药工业有限公司。
北美胃轻瘫市场 - 按类型
Strategic insights for North America Gastroparesis involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 1,488.03 Million |
| Market Size by 2027 | US$ 2,032.27 Million |
| Global CAGR (2020 - 2027) | 4.6% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2027 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Gastroparesis refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Gastroparesis Market is valued at US$ 1,488.03 Million in 2020, it is projected to reach US$ 2,032.27 Million by 2027.
As per our report North America Gastroparesis Market, the market size is valued at US$ 1,488.03 Million in 2020, projecting it to reach US$ 2,032.27 Million by 2027. This translates to a CAGR of approximately 4.6% during the forecast period.
The North America Gastroparesis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Gastroparesis Market report:
The North America Gastroparesis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Gastroparesis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Gastroparesis Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Gastroparesis Market
